Related Experiment Video
Updated: Mar 24, 2026
High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
Published on: January 27, 2013
Therapeutic targeting of two-pore-domain potassium (K(2P)) channels in the cardiovascular system
Felix Wiedmann1, Constanze Schmidt1, Patrick Lugenbiel1
1Department of Cardiology, University of Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Abstract:
The improvement of treatment strategies in cardiovascular medicine is an ongoing process that requires constant optimization. The ability of a therapeutic intervention to prevent cardiovascular pathology largely depends on its capacity to suppress the underlying mechanisms. Attenuation or reversal of disease-specific pathways has emerged as a promising paradigm, providing a mechanistic rationale for patient-tailored therapy. Two-pore-domain K(+) (K(2P)) channels conduct outward K(+) currents that stabilize the resting membrane potential and facilitate action potential repolarization. K(2P) expression in the cardiovascular system and polymodal K2P current regulation suggest functional significance and potential therapeutic roles of the channels. Recent work has focused primarily on K(2P)1.1 [tandem of pore domains in a weak inwardly rectifying K(+) channel (TWIK)-1], K(2P)2.1 [TWIK-related K(+) channel (TREK)-1], and K(2P)3.1 [TWIK-related acid-sensitive K(+) channel (TASK)-1] channels and their role in heart and vessels. K(2P) currents have been implicated in atrial and ventricular arrhythmogenesis and in setting the vascular tone. Furthermore, the association of genetic alterations in K(2P)3.1 channels with atrial fibrillation, cardiac conduction disorders and pulmonary arterial hypertension demonstrates the relevance of the channels in cardiovascular disease. The function, regulation and clinical significance of cardiovascular K(2P) channels are summarized in the present review, and therapeutic options are emphasized.
Insights
Two-pore-domain potassium (K2P) channels are crucial in cardiovascular health, influencing heart rhythm and vascular tone. Understanding their function offers new therapeutic strategies for cardiovascular diseases.
Area of Science:
- Cardiovascular Medicine
- Molecular Physiology
- Ion Channel Biology
Background:
- Cardiovascular disease treatment requires optimizing therapeutic strategies by targeting underlying mechanisms.
- Two-pore-domain potassium (K2P) channels regulate membrane potential and action potential repolarization.
- K2P channels are expressed in the cardiovascular system and their regulation suggests therapeutic potential.
Purpose of the Study:
- To review the function, regulation, and clinical significance of K2P channels in cardiovascular diseases.
- To emphasize the therapeutic potential of targeting K2P channels for patient-tailored therapies.
Main Methods:
- Literature review focusing on K2P1.1 (TWIK-1), K2P2.1 (TREK-1), and K2P3.1 (TASK-1) channels.
- Analysis of studies implicating K2P currents in cardiac and vascular functions.
- Examination of genetic alterations in K2P3.1 channels and their association with cardiovascular pathologies.
Main Results:
- K2P currents play a role in atrial and ventricular arrhythmogenesis and vascular tone regulation.
- Genetic mutations in K2P3.1 channels are linked to atrial fibrillation, cardiac conduction disorders, and pulmonary arterial hypertension.
- Specific K2P channels (K2P1.1, K2P2.1, K2P3.1) are key players in cardiovascular physiology and disease.
Conclusions:
- K2P channels are significant targets for novel therapeutic interventions in cardiovascular medicine.
- Understanding K2P channel function provides a mechanistic basis for developing patient-tailored cardiovascular therapies.
- Further research into K2P channel regulation and modulation is warranted for clinical application.
More Related Videos
08:11Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
07:19Recording of Inward Rectifying K+ Currents in Freshly Isolated Basilar Artery Smooth Muscle Cells by Patch Clamp Technique
Published on: February 7, 2025
Related Concept Videos
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
01:24Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
01:24Non-gated Ion Channels
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:26Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...